Fermenta Biotech Ltd
Fermenta Biotech Ltd (FERMENTA) last traded at ₹462, a market capitalisation of ₹1,359 crore, on a P/E of 24.8. Over the past 52 weeks the stock has ranged between ₹249 and ₹580. Fermenta Biotech Ltd last reported results for the quarter ended Jun 2026, with sales of ₹122 crore and net profit of ₹9.53 crore. Figures are as of 25 Aug 2026 and are not real time.
Fermenta Biotech Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Fermenta Biotech Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹122 cr, down 10.6% from ₹136 cr a year earlier. Net profit was ₹9.53 cr, down 55.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 95.03 | 156 | 140 | 136 | 130 | 137 | 122 | 122 |
| Expenses | 76.25 | 103 | 103 | 108 | 104 | 112 | 102 | 104 |
| Operating profit | 18.78 | 53.27 | 36.95 | 28.24 | 26.64 | 24.96 | 20 | 18.06 |
| OPM % | 19.76% | 34.04% | 26.42% | 20.73% | 20.46% | 18.17% | 16.45% | 14.83% |
| Other income | 2.88 | 2.23 | 3.89 | 8.77 | 5.43 | 0.92 | 14.14 | 4.37 |
| Interest | 3.69 | 4.08 | 2.99 | 3.11 | 2.58 | 3.03 | 2.82 | 2.54 |
| Depreciation | 6.15 | 6.08 | 5.86 | 5.81 | 5.41 | 5.37 | 5.11 | 5.2 |
| Profit before tax | 11.82 | 45.34 | 31.99 | 28.09 | 24.08 | 17.48 | 26.21 | 14.69 |
| Tax % | 5.92% | 16.43% | -4.19% | 23.07% | 25.17% | 31.24% | 29.03% | 35.13% |
| Net profit | 11.12 | 37.89 | 33.32 | 21.6 | 18.03 | 12.02 | 18.6 | 9.53 |
| EPS (₹) | 3.87 | 12.54 | 11.68 | 7.42 | 6.14 | 4.31 | 6.52 | 3.31 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Fermenta Biotech Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 376 | 397 | 349 | 335 | 468 | 523 | 511 |
| Operating profit | 83 | 62 | 18 | 28 | 115 | 101 | 90 |
| OPM % | 22% | 16% | 5% | 8% | 25% | 19% | 18% |
| Net profit | 43 | 15 | -53 | -24 | 76 | 70 | 58 |
| EPS (₹) | 15.46 | 5.25 | -17.36 | -7.84 | 26.12 | 24.39 | 20.28 |
TTM is the trailing twelve months to the most recent quarter.
Fermenta Biotech Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 7%
- 3 Years
- 14%
- TTM
- -3%
- 10 Years
- 51%
- 5 Years
- 7%
- 3 Years
- 65%
- TTM
- -48%
- 10 Years
- 24%
- 5 Years
- 10%
- 3 Years
- 49%
- 1 Year
- 47%
- 10 Years
- 13%
- 5 Years
- 7%
- 3 Years
- 13%
- Last Year
- 16%
Fermenta Biotech Ltd shareholding pattern
Promoters held 64.08% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.13% and DIIs 0.04%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.06% | 62.06% | 64.08% | 64.08% | 64.08% | 64.08% | 64.08% | 64.08% |
| FIIs | 0.05% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.13% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.04% |
| Public | 36.41% | 36.98% | 35.00% | 35.00% | 34.75% | 33.99% | 33.32% | 33.19% |
| No. of shareholders | 13,221 | 12,922 | 12,930 | 12,845 | 13,760 | 14,139 | 13,661 | 14,131 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Fermenta Biotech Ltd corporate filings
- Intimation of investor meeting to be held on August 21, 2026.Company Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has issued an intimation regarding an investor meeting scheduled to…
Read the full analysis - Revision in credit rating.Company Updatemedium impact
Cruxal's analysis: Fermenta Biotech Limited has received a credit rating upgrade from CARE Ratings, with…
Read the full analysis - Newspaper publication of Unaudited financial results for quarter ended June 30, 2026.Company Updatehigh impact
Cruxal's analysis: Fermenta Biotech Limited reported a sharp decline in consolidated financial performance…
Read the full analysis - Declaration of voting results of the 74th Annual General Meeting.AGM/EGMlow impact
Cruxal's analysis: Fermenta Biotech Limited has successfully concluded its 74th Annual General Meeting…
Read the full analysis - Scrutinizers report of 74th Annual General Meeting.AGM/EGMlow impact
Cruxal's analysis: Fermenta Biotech Limited has successfully concluded its 74th Annual General Meeting held…
Read the full analysis - Outcome of 74th Annual General Meeting.AGM/EGMlow impact
Cruxal's analysis: Fermenta Biotech Limited has successfully concluded its 74th Annual General Meeting…
Read the full analysis - Presentation for shareholders at 74th Annual General Meeting (''AGM'')Company Updatehigh impact
Cruxal's analysis: Fermenta Biotech Limited has released its 74th Annual General Meeting presentation…
Read the full analysis - Earnings presentation - Q1/FY27Company Updatehigh impact
Cruxal's analysis: Fermenta Biotech Limited reported Q1 FY27 consolidated revenue of INR 126.2 crore…
Read the full analysis - Press release regarding unaudited financial results of Q1FY27.Company Updatemedium impact
Cruxal's analysis: Fermenta Biotech Limited reported Q1FY27 consolidated revenue of INR 126.2 crore…
Read the full analysis - Outcome of Board meeting and unaudited financial results - June 30, 2026.Board Meetinghigh impact
Cruxal's analysis: Fermenta Biotech Limited reported consolidated revenue from operations of 121.82 crore…
Read the full analysis - Intimation of investor(s) meeting(s).Company Updatelow impact
Cruxal's analysis: Fermenta Biotech Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....Board Meetinglow impact
Cruxal's analysis: Fermenta Biotech Limited has announced that its Board of Directors will convene on…
Read the full analysis - Press release - listing of shares on NSECompany Updatemedium impact
Cruxal's analysis: Fermenta Biotech Ltd. has issued a press release announcing the listing of its shares on…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Fermenta Biotech Ltd
Cruxal reads every Fermenta Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.